Dominic Pilon

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Major Depressive Disorder

Prognostic Factors

Ejection Fraction

Top Venues

Journal of medical economics

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Mehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, Laura Morrison, Lilian Diaz, Annalise Hilts, Patrick Lefebvre, Dominic Pilon, Daniel J George
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer. The oncologist (2024)
Maryia Zhdanava, Amanda Teeple, Dominic Pilon, Aditi Shah, Gabrielle Caron-Lapointe, Kruti Joshi
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of medical economics (2023)
Maryia Zhdanava, Amanda Teeple, Dominic Pilon, Aditi Shah, Gabrielle Caron-Lapointe, Kruti Joshi
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of medical economics 26 (1) (2023)
Kruti Joshi, Dominic Pilon, Aditi Shah, Christopher Holiday, Swapna Karkare, Maryia Zhdanava
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on Esketamine intranasal spray and covered by US commercial health plans. Journal of medical economics (2023)
Maryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, Sumesh Kachroo, Patrick Lefebvre, Dominic Pilon
Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States. Crohn's & colitis 360 5 (3) (2023)
Kruti Joshi, Dominic Pilon, Aditi Shah, Christopher Holiday, Swapna Karkare, Maryia Zhdanava
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans. Journal of medical economics 26 (1) (2023)
Maryia Zhdanava, Amanda Teeple, Dominic Pilon, Aditi Shah, Gabrielle Caron-Lapointe, Kruti Joshi
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of medical economics 26 (1) (2023)
Dominic Pilon, Zhijie Ding, Erik Muser, Ameur M Manceur, Maude Vermette-Laforme, Marie-Hélène Lafeuille, Patrick Lefebvre
Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents. Crohn's & colitis 360 4 (3) (2022)
Dominic Pilon, Zhijie Ding, Erik Muser, Ameur M Manceur, Maude Vermette-Laforme, Marie-Hélène Lafeuille, Patrick Lefebvre
Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents. Crohn's & colitis 360 4 (3) (2022)
Dominic Pilon, Kruti Joshi, John J Sheehan, Miriam L Zichlin, Peter Zuckerman, Patrick Lefebvre, Paul E Greenberg
Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis. PloS one 14 (10) (2019)